It is possible that the main title of the report Streptococcus, Group B is not the name you expected. Please check the synonyms listing to find the alternate name(s) and disorder subdivision(s) covered by this report.
- Group B Streptococcal Septicemia of the Newborn
- Lancefield Group B Streptococcus
- Sepsis of the Newborn
- Streptococcus Agalactiae
Group B streptococcus (group B strep) is a type of bacteria that causes infection among newborns, pregnant women or women after childbirth, females after gynecologic surgery, and older male and female patients with other serious diseases.
Group B strep remains the most common cause among newborns (neonates) of infection of the blood (septicemia) and of the brain (meningitis). The responsible bacterium, usually S. agalactiae, may be found most often in the vagina and rectum of females and may be transmitted sexually, as well as to a fetus as the infant passes through the birth canal.
Group B strep infection of newborns may be prevented by giving pregnant women who are carriers antibiotics through the vein (intravenously) during labor. The U.S. Centers for Disease Control and Prevention (CDC) recommend that any pregnant woman who has had a baby with group B strep disease in the past, who has a bladder (urinary tract) infection caused by group B strep, or who tests positive for group B strep during pregnancy should receive antibiotics during labor.
Prevention and prompt treatment are important because group B strep infections may become life-threatening among newborns.
GBS disease is said to be early onset if it is obvious within the first week of life. It is said to be late onset if the disease is evident after the first week of life and before the end of the first three months. Those at greatest risk of GBS disease are newborn children of infected mothers, women after childbirth, females after gynecologic surgery and older male and female patients with other serious diseases.
Group B Strep Association
P.O. Box 16515
Chapel Hill, NC 27516
Centers for Disease Control and Prevention
1600 Clifton Road NE
Atlanta, GA 30333
NIH/National Institute of Allergy and Infectious Diseases
Office of Communications and Government Relations
6610 Rockledge Drive, MSC 6612
Bethesda, MD 20892-6612
Genetic and Rare Diseases (GARD) Information Center
PO Box 8126
Gaithersburg, MD 20898-8126
For a Complete Report
This is an abstract of a report from the National Organization for Rare Disorders (NORD). A copy of the complete report can be downloaded free from the NORD website for registered users. The complete report contains additional information including symptoms, causes, affected population, related disorders, standard and investigational therapies (if available), and references from medical literature. For a full-text version of this topic, go to www.rarediseases.org and click on Rare Disease Database under "Rare Disease Information".
The information provided in this report is not intended for diagnostic purposes. It is provided for informational purposes only. NORD recommends that affected individuals seek the advice or counsel of their own personal physicians.
It is possible that the title of this topic is not the name you selected. Please check the Synonyms listing to find the alternate name(s) and Disorder Subdivision(s) covered by this report
This disease entry is based upon medical information available through the date at the end of the topic. Since NORD's resources are limited, it is not possible to keep every entry in the Rare Disease Database completely current and accurate. Please check with the agencies listed in the Resources section for the most current information about this disorder.
For additional information and assistance about rare disorders, please contact the National Organization for Rare Disorders at P.O. Box 1968, Danbury, CT 06813-1968; phone (203) 744-0100; web site www.rarediseases.org or email firstname.lastname@example.org
Last Updated: 5/12/2009
Copyright 1992, 2003, 2009 National Organization for Rare Disorders, Inc.